LIP
XBI icon

Lighthouse Investment Partners’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Lighthouse Investment Partners’s Portfolio XBI Stock Details XBI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-2,712
Closed -$346K – 974
2026
Q1 		$346K Buy
+2,712
New +$339K 0.01% 576
2024
Q4 		– Sell
-19,862
Closed -$1.96M – 666
2024
Q3 		$1.96M Buy
+19,862
New +$1.95M 0.07% 263

Other funds holding XBI

BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $71.2B AUM 48.86% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return
JFG
Jefferies Financial Group New York $15.2B AUM 55.75% 1-Year Est. Return

Lighthouse Investment Partners's XBI Position: Q2 2026 in Review

Lighthouse Investment Partners sold out of State Street SPDR S&P Biotech ETF (XBI) in Q2 2026, closing a stake of 2,712 shares — an estimated $346K sold.

Lighthouse Investment Partners first reported a position in XBI in Q3 2024 and held it in 2 quarters. The position peaked at $1.96M in Q3 2024. 933 funds tracked by Wall St. Rank hold XBI as of Q2 2026.

  • Lighthouse Investment Partners reported no remaining State Street SPDR S&P Biotech ETF position as of Q2 2026 after selling out during the quarter.
  • Lighthouse Investment Partners sold 2,712 State Street SPDR S&P Biotech ETF shares in Q2 2026, an estimated $346K.
  • Lighthouse Investment Partners first reported a position in State Street SPDR S&P Biotech ETF in Q3 2024 and held it in 2 quarters.
  • Lighthouse Investment Partners's State Street SPDR S&P Biotech ETF position peaked at $1.96M in Q3 2024.
  • 933 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q2 2026.

Based on Lighthouse Investment Partners's 13F filing for Q2 2026, filed 14 Aug 2026.